These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 8993829

  • 1. Receptor tyrosine kinase signaling in vascular development.
    Merenmies J, Parada LF, Henkemeyer M.
    Cell Growth Differ; 1997 Jan; 8(1):3-10. PubMed ID: 8993829
    [No Abstract] [Full Text] [Related]

  • 2. Possible involvement of VEGF-FLT tyrosine kinase receptor system in normal and tumor angiogenesis.
    Shibuya M, Seetharam L, Ishii Y, Sawano A, Gotoh N, Matsushime H, Yamaguchi S.
    Princess Takamatsu Symp; 1994 Jan; 24():162-70. PubMed ID: 8983073
    [Abstract] [Full Text] [Related]

  • 3. Two independent mechanisms essential for tumor angiogenesis: inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway.
    Siemeister G, Schirner M, Weindel K, Reusch P, Menrad A, Marmé D, Martiny-Baron G.
    Cancer Res; 1999 Jul 01; 59(13):3185-91. PubMed ID: 10397264
    [Abstract] [Full Text] [Related]

  • 4. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases.
    Meyer M, Clauss M, Lepple-Wienhues A, Waltenberger J, Augustin HG, Ziche M, Lanz C, Büttner M, Rziha HJ, Dehio C.
    EMBO J; 1999 Jan 15; 18(2):363-74. PubMed ID: 9889193
    [Abstract] [Full Text] [Related]

  • 5. [Role of the ETS transcription factors in the control of endothelial-specific gene expression and in angiogenesis].
    Lelièvre E, Lionneton F, Soncin F.
    Bull Cancer; 2001 Feb 15; 88(2):137-42. PubMed ID: 11257588
    [Abstract] [Full Text] [Related]

  • 6. Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro.
    Grosskreutz CL, Anand-Apte B, Dupláa C, Quinn TP, Terman BI, Zetter B, D'Amore PA.
    Microvasc Res; 1999 Sep 15; 58(2):128-36. PubMed ID: 10458928
    [Abstract] [Full Text] [Related]

  • 7. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium.
    Fong GH, Rossant J, Gertsenstein M, Breitman ML.
    Nature; 1995 Jul 06; 376(6535):66-70. PubMed ID: 7596436
    [Abstract] [Full Text] [Related]

  • 8. Regulation of angiogenesis via vascular endothelial growth factor receptors.
    Veikkola T, Karkkainen M, Claesson-Welsh L, Alitalo K.
    Cancer Res; 2000 Jan 15; 60(2):203-12. PubMed ID: 10667560
    [No Abstract] [Full Text] [Related]

  • 9. Angiogenesis in embryos and ischemic diseases.
    Breier G, Damert A, Plate KH, Risau W.
    Thromb Haemost; 1997 Jul 15; 78(1):678-83. PubMed ID: 9198238
    [Abstract] [Full Text] [Related]

  • 10. Vascular endothelial growth factor modulates the Tie-2:Tie-1 receptor complex.
    Tsiamis AC, Morris PN, Marron MB, Brindle NP.
    Microvasc Res; 2002 Mar 15; 63(2):149-58. PubMed ID: 11866538
    [Abstract] [Full Text] [Related]

  • 11. [Growth factors binding heparin: FGF and VEGF. Physiological and physiopathological importance, therapeutic implications in diabetic retinopathy].
    Favard C, Patry V, Prats H, Plouet J, Bayard F.
    Journ Annu Diabetol Hotel Dieu; 1995 Mar 15; ():39-51. PubMed ID: 7602891
    [No Abstract] [Full Text] [Related]

  • 12. The adapter protein, Grb10, is a positive regulator of vascular endothelial growth factor signaling.
    Giorgetti-Peraldi S, Murdaca J, Mas JC, Van Obberghen E.
    Oncogene; 2001 Jul 05; 20(30):3959-68. PubMed ID: 11494124
    [Abstract] [Full Text] [Related]

  • 13. VEGF receptor signal transduction.
    Matsumoto T, Claesson-Welsh L.
    Sci STKE; 2001 Dec 11; 2001(112):re21. PubMed ID: 11741095
    [Abstract] [Full Text] [Related]

  • 14. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
    Tille JC, Wood J, Mandriota SJ, Schnell C, Ferrari S, Mestan J, Zhu Z, Witte L, Pepper MS.
    J Pharmacol Exp Ther; 2001 Dec 11; 299(3):1073-85. PubMed ID: 11714897
    [Abstract] [Full Text] [Related]

  • 15. Vascular endothelial growth factor: environmental controls and effects in angiogenesis.
    Hlatky L, Hahnfeldt P, Tsionou C, Coleman CN.
    Br J Cancer Suppl; 1996 Jul 11; 27():S151-6. PubMed ID: 8763869
    [No Abstract] [Full Text] [Related]

  • 16. Cartilage to bone--angiogenesis leads the way.
    Harper J, Klagsbrun M.
    Nat Med; 1999 Jun 11; 5(6):617-8. PubMed ID: 10371495
    [No Abstract] [Full Text] [Related]

  • 17. Growth factor signaling pathways in vascular development.
    Tallquist MD, Soriano P, Klinghoffer RA.
    Oncogene; 1999 Dec 20; 18(55):7917-32. PubMed ID: 10630644
    [Abstract] [Full Text] [Related]

  • 18. VEGF-FLT1 receptor system: a new ligand-receptor system involved in normal and tumor angiogenesis.
    Birnbaum D.
    Jpn J Cancer Res; 1995 Jul 20; 86(7):inside cover. PubMed ID: 7559075
    [No Abstract] [Full Text] [Related]

  • 19. [Anti-angiogenic reagents].
    Shibuya M.
    Tanpakushitsu Kakusan Koso; 2000 Apr 20; 45(6 Suppl):1182-7. PubMed ID: 10771693
    [No Abstract] [Full Text] [Related]

  • 20. rAAV-mediated long-term liver-generated expression of an angiogenesis inhibitor can restrict renal tumor growth in mice.
    Davidoff AM, Nathwani AC, Spurbeck WW, Ng CY, Zhou J, Vanin EF.
    Cancer Res; 2002 Jun 01; 62(11):3077-83. PubMed ID: 12036917
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.